The Clinical Utility and Impact of Next Generation Sequencing in Gynecologic Cancers
Next generation sequencing (NGS) has facilitated the identification of molecularly targeted therapies. However, clinical utility is an emerging challenge. Our objective was to identify the clinical utility of NGS testing in gynecologic cancers. A retrospective review of clinico-pathologic data was p...
Main Authors: | Vijaya Kadam Maruthi, Mahyar Khazaeli, Devi Jeyachandran, Mohamed Mokhtar Desouki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/5/1352 |
Similar Items
-
Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing
by: Dingani Nkosi, et al.
Published: (2022-04-01) -
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
by: Nathalie E. Synhaeve, et al.
Published: (2018-11-01) -
Utility of next-generation sequencing in the diagnosis of neurological disorders
by: Adnan Firdous Raina, et al.
Published: (2023-01-01) -
HLA genotyping by next-generation sequencing of complementary DNA
by: Hidenobu Segawa, et al.
Published: (2017-11-01) -
Next-generation sequencing analysis of the molecular spectrum of thalassemia in Southern Jiangxi, China
by: Tong Yang, et al.
Published: (2023-08-01)